Pharm Capsules

Incorporating pharmacists into opioid use disorder treatment improves patient outcomes, complex interplay between ...

NOVEMBER 13, 2024

Immigrants With Chronic HBV Are Vulnerable to Lapses in Antiviral Use

Due to multiple factors, immigrants living in the United States who have chronic hepatitis B virus (HBV) are ...

NOVEMBER 8, 2024

Proposed FDA Rule Could Enable POC Hepatitis B Testing

Recent steps by the FDA and National Institutes of Health increase the likelihood of point-of-care (POC) testing ...

OCTOBER 18, 2024

All U.S. Adults Should Be Tested for HBV at Least Once

The CDC changed its recommendation for hepatitis B testing, because more than half the people who have HBV do not ...

MARCH 13, 2023

TAF- or TDF-Backbone? Both Appear Efficacious for HIV/HBV Co-Infection

A regimen for treating people with HIV and HBC coinfection with a TAF backbone has similar efficacy with one that ...

JULY 29, 2022

ACIP: More Choice for HepB Vaccination

There are now four hepatitis B vaccines recommended for adults, which should help reach the HHS goals for ...

MARCH 28, 2022

Treating All U.S. Hepatitis B Patients Could Lead to Large Cost Savings

Treating all U.S. patients with hepatitis B virus would significantly decrease disease burden, according to data ...

FEBRUARY 22, 2022

ACIP Recommends ‘Universal’ Adult HBV Vaccine—But Not for All

The risk-based vaccination strategy has been partially successful with initial decreases, but new HBV infections ...

NOVEMBER 18, 2021